Form 4 · Filed Aug 1, 2026, 12:00 AM UTC
JANX/Janux Therapeutics, Inc.
Campbell David Alan — President and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | G | other | 123,840 | $0 | — | 264,742 |
Source: SEC EDGAR raw filing ↗ · Accession 0001864158-26-000006